Patents Assigned to Fibrogenex, Inc.
  • Method for preparing cellular fibronectin
    Patent number: 5750378
    Abstract: A method for producing cellular fibronectin, said method comprising incubating fibronectin-producing cells in a fibronectin production medium comprising: (a) 1.0-3.5 g/L bicarbonate salt; (b) 1.0-5.0 g/L glucose; (c) 10-30 .mu.g/L dexamethasone; (d) 1-10 g/L hydrolyzed protein; and (e) 5-15 .mu.g/L insulin.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: May 12, 1998
    Assignee: Fibrogenex, Inc.
    Inventors: Clyde R. Goodheart, Ralph H. Silverman
  • Method for treating cancer resections
    Patent number: 5354269
    Abstract: A method for preparing fibronectin and further a process for treating cancer resections which prevents or reduces local recurrences of cancer in procedures in which cancerous tissues are resected comprising the steps of: mixing a pharmaceutical fibronectin with a suspending medium to provide a fibronectin composition; applying the fibronectin composition to a surgically exposed tissue from the cancer resection; and closing the surgically exposed tissue using conventional suturing techniques.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: October 11, 1994
    Assignee: Fibrogenex, Inc.
    Inventors: Clyde R. Goodheart, Ralph H. Silverman, M. Satya Murthy, Edward F. Scanlon